Do molecular markers predict survival in non-small-cell lung cancer?

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 4 PART I, 1998, Pages 1093-1097

  Greatens, Todd M ^a   Niehans, Gloria A ^a   Rubins, Jeffrey B ^a   Jessurun, Jose ^a   Kratzke, Robert A ^a   Maddaus, Michael A ^a   Niewoehner, Dennis E ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG NON SMALL CELL CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; GENES, P53; GENES, RAS; GENETIC MARKERS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031979703     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.4.9707108     Document Type: Article

References (13)

1. Strauss, G. M., D. J. Kwiatowski, D. H. Harple, T. J. Lynch, A. T. Skarin, and D. J. Sugarbaker. 1995. Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J. Clin. Oncol. 13:1265-1279.
2. Harpole, D. H., Jr., J. E. Herndon, II, W. G. Wolfe, J. D. Iglehart, and J. R. Marks. 1995. A prognostic model of recurrences and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res. 55:51-56.
3. Kern, J. A., R. J. C. Slebos, B. Top, S. Rodenhuis, D. Lager, R. A. Robinson, D. Weiner, and D. A. Schwartz. 1994. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest. 93:516-520.
4. Slebos, R. J. C., R. E. Kibbelaar, O. Dalesio, A. Kooistra, J. Stam, C. J. L. M. Meijer, S. S. Wagenaar, R. G. J. R. A. Vanderschueren, N. van Zandwijk, W. J. Mooi, J. L. Bos, and S. Rodenhuis. 1990. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med. 323:561-565.
5. Rosell, R., S. Li, Z. Skacel, J. L. Mate, J. Maestre, M. Canela, E. Tolosa, P. Armengol, A. Barnadas, and A. Ariza. 1993. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene 8:2407-2412.
6. Horio, Y., T. Takahashi, T. Kuroishi, K. Hibi, M. Suyama, T. Niimi, K. Shimokata, K. Yamakawa, Y. Nakamura, R. Ueda, and T. Takahashi. 1993. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res. 53:1-4.
7. Mitsudomi, T., T. Oyama, T. Kusano, T. Osaki, R. Nakanishi, and T. Shirakusa. 1993. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J. Natl. Cancer Inst. 85:2018-2023.
8. Quinlan, D. C., A. G. Davidson, C. L. Summers, H. E. Warden, and H. M. Doshi. 1992. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res. 52:4828-4831.
9. Carbone, D. P., T. Mitsudomi, I. Chiba, S. Piantadosi, V. Rusch, J. A. Nowak, D. McIntire, D. Slamon, A. Gazdar, and J. Minna. 1994. p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. Chest 106(Suppl.):377S-381S.
10. Pezzella, F., H. Turley, I. Kuzu, M. F. Tungekar, M. S. Dunnill, C. B. Pierce, A. Harris, K. C. Gatter, and D. Y. Mason. 1993. bcl-2 protein in non-small-cell lung carcinoma. N. Engl J. Med. 329:690-694.
11. Fontanini, G., S. Vignati, D. Bigini, A. Mussi, M. Lucchi, C. A. Angeletti, F. Basolo, and G. Bevilacqua. 1995. bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br. J. Cancer 71:1003-1007.
12. neu expression in human lung adenocarcinoma predicts shortened survival. Cancer Res. 50:5184-5189.
13. Tateishi, M., T. Ishida, T. Mitsudomi, S. Kaneko, and K. Sugimachi. 1991. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur. J. Cancer 27:1372-1375.